Medical Developments (Australia) Probability of Future Stock Price Finishing Under 1.0
| MVP Stock | 0.42 0.01 2.33% |
Medical |
Medical Developments Target Price Odds to finish below 1.0
The tendency of Medical Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 1.00 after 90 days |
| 0.42 | 90 days | 1.00 | close to 99 |
Based on a normal probability distribution, the odds of Medical Developments to stay under 1.00 after 90 days from now is close to 99 (This Medical Developments International probability density function shows the probability of Medical Stock to fall within a particular range of prices over 90 days) . Probability of Medical Developments price to stay between its current price of 0.42 and 1.00 at the end of the 90-day period is about 97.0 .
Assuming the 90 days trading horizon Medical Developments has a beta of 0.0723. This indicates as returns on the market go up, Medical Developments average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Medical Developments International will be expected to be much smaller as well. Additionally Medical Developments International has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Medical Developments Price Density |
| Price |
Predictive Modules for Medical Developments
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medical Developments. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Medical Developments Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medical Developments is not an exception. The market had few large corrections towards the Medical Developments' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medical Developments International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medical Developments within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.07 |
Medical Developments Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medical Developments for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medical Developments can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medical Developments generated a negative expected return over the last 90 days | |
| Medical Developments has some characteristics of a very speculative penny stock | |
| Medical Developments has high historical volatility and very poor performance | |
| The company reported the revenue of 33.15 M. Net Loss for the year was (40.99 M) with profit before overhead, payroll, taxes, and interest of 22.21 M. | |
| Medical Developments International has accumulated about 24.66 M in cash with (10.78 M) of positive cash flow from operations. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Medical Developments International Insiders Placed Bullish Bets Worth AU3.36m - Yahoo Finance |
Medical Developments Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medical Stock often depends not only on the future outlook of the current and potential Medical Developments' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medical Developments' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88.6 M | |
| Cash And Short Term Investments | 9.7 M |
Medical Developments Technical Analysis
Medical Developments' future price can be derived by breaking down and analyzing its technical indicators over time. Medical Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medical Developments International. In general, you should focus on analyzing Medical Stock price patterns and their correlations with different microeconomic environments and drivers.
Medical Developments Predictive Forecast Models
Medical Developments' time-series forecasting models is one of many Medical Developments' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medical Developments' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Medical Developments
Checking the ongoing alerts about Medical Developments for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medical Developments help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medical Developments generated a negative expected return over the last 90 days | |
| Medical Developments has some characteristics of a very speculative penny stock | |
| Medical Developments has high historical volatility and very poor performance | |
| The company reported the revenue of 33.15 M. Net Loss for the year was (40.99 M) with profit before overhead, payroll, taxes, and interest of 22.21 M. | |
| Medical Developments International has accumulated about 24.66 M in cash with (10.78 M) of positive cash flow from operations. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Medical Developments International Insiders Placed Bullish Bets Worth AU3.36m - Yahoo Finance |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.